ArticleScientific reports2025
Fractures incidence and its association on mortality in multiple myeloma patients: a nationwide cohort study (CAREMM-2105 study).
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Multiple myeloma (MM) is known to compromise bone integrity, leading to an increased risk of fractures, which compromise the quality of life and increase mortality rates. This study investigated the incidence of fractures in MM patients and explored the association between fractures after MM diagnosis and mortality using the Korean National Health Insurance Service database. Fracture incidence was compared between MM patients (n = 9365) and 1:1 matched control group from general population. MM patients demonstrated a significantly higher cumulative incidence of fractures, and vertebral and hip fractures presented a particularly elevated hazard ratio (1.36 [95% CI 1.18-1.55] and 1.47 [95% CI 1.10-1.97], respectively). Furthermore, the presence of fracture within the first year of MM diagnosis were associated with increased mortality (any fracture-HR 1.37 [95% CI 1.19-1.58]; vertebral fractures-HR 1.39 [95% CI 1.19-1.63]; hip fractures-HR 2.46 [95% CI 1.52-3.99]; upper limb fractures-HR 1.94 [95% CI 1.32-2.87]). These results showed an increased risk of fracture and a correlation between fractures and increased mortality in MM patients, with hip fractures notably doubling the mortality risk. These findings underscore the importance of monitoring and managing bone health in MM patients to improve survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.